Genetics of Deafness, from Diagnostics, Prognostics to Therapeutics
A special issue of Genes (ISSN 2073-4425). This special issue belongs to the section "Human Genomics and Genetic Diseases".
Deadline for manuscript submissions: closed (20 September 2023) | Viewed by 4352
Special Issue Editors
Interests: pediatric otology; cochlear implantation; endoscopic ear surgery; genetics of deafness; minimally invasive ear surgery
Special Issue Information
Dear Colleagues,
Hearing impairments are the most common inherited sensory disorders. The World Health Organization (WHO) estimates that ~3,400 children worldwide experience disabling hearing impairment, for which genetic factors are the predominant cause. Despite these staggering statistics, the diagnostics and prognostics remain suboptimal in clinical practice, and available therapies are severely limited.
In this Special Issue, we aim to provide a platform for all aspects of diagnostic, prognostic, and therapeutic research into the genetics of hearing impairment. We would like to invite scientists to submit manuscripts that focus on the application of next-generation sequencing technologies and bioinformatics analyses to diagnostics, the identification of outcome measures and biomarkers for the prognostics, and the optimization of gene therapy and drug delivery methods for therapeutics. Contributions in the format of original research papers and review manuscripts will both be welcome in this Special Issue.
Prof. Dr. Chen-Chi Wu
Prof. Dr. Byung Yoon Choi
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- hearing loss
- next-generation sequencing
- long-read sequencing
- biomarkers and outcome measures
- gene therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.